| Linagliptin Impurity H |
利格列汀杂质H |
1646355-34-1 |
| 1-(5-Methoxy-2-Methyl-4-nitrophenyl)-N,N-diMethylpiperidin-4-aMine |
BRIGATINIB 中间体 |
1089279-90-2 |
| Gefitinib iMpurity |
吉非替尼杂质 |
1608115-59-8 |
| Dabigatran Etexilate iMpurity I |
达比加群乙二酸杂质I |
255706-13-9 |
| Linagliptin Impurity K |
利格列汀杂质K |
1638744-06-5 |
| Etoricoxib Impurity 10 |
依托考昔杂质10 |
316149-01-6 |
| Dabigatran iMpurity F |
达比加群杂质F |
1642853-67-5 |
| Parecoxib Sodium Impurity 14 |
间位帕瑞昔布 |
1709956-89-7 |
| 2-(((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)amino)-2-oxoacetic acid |
依度沙班杂质 |
767625-11-6 |
| Linagliptin Impurity F |
利格列汀杂质F |
1673546-62-7 |
| Linagliptin iMpurity E |
利拉利汀杂质E |
1446263-38-2 |
| 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) |
托法替尼杂质 |
477600-76-3 |
| R-afatinib |
R-阿法替尼 |
945553-91-3 |
| Dabigatran etexilate Impurity R |
达比加群乙二酸杂质R |
1610758-20-7 |
| Dabigatran iMpurity L |
达比加群杂质L |
1422435-41-3 |
| 4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide |
4-(4-氨基-3-氯苯氧基)-7-甲氧基喹啉-6-羧酸 |
417722-93-1 |
| Nintedanib impurity I |
尼达尼布I杂质 |
334951-61-0 |
| 4-Aminobenzoic acid |
对氨基苯甲酸 |
150-13-0 |
| phenyl cyanate |
氰酸苯酯 |
1122-85-6 |
| 2',4'-DIMETHYLACETANILIDE |
2',4'-二甲基乙酰苯胺 |
2050-43-3 |
QQ
